Plant-derived compound has antimicrobial and anti-inflammatory effects against periodontal disease

A powder based on morin, a natural compound extracted from plants such as guava leaves, apple and fig peels, certain teas, and almonds, has shown antimicrobial, anti-inflammatory, and antioxidant effects against bacteria that cause periodontal disease. It is expected that the substance, released in a controlled manner through polymers, will help with nonsurgical treatments as an alternative to antibiotics for controlling microorganisms.

In in vitro laboratory studies, researchers at the Araraquara School of Dentistry at São Paulo State University (FOAr-UNESP) in Brazil tested morin on a multispecies biofilm formed by various species of bacteria that simulated the effects of the disease on patients’ gums.

The results were published in the Archives of Oral Biology. The study was conducted by Luciana Solera Sales during her doctoral studies at FOAr-UNESP, under the supervision of Fernanda Lourenção Brighenti. FAPESP supported the study through a doctorate and a research internship abroad.

Other researchers involved in the study included Andréia Bagliotti Meneguin from the Faculty of Pharmaceutical Sciences of Araraquara (FCFAr) at UNESP; Hernane da Silva Barud from the University of Araraquara (UNIARA); and Michael Robert Milward from the Faculty of Dentistry at the University of Birmingham in England.  

“At the moment, we have a fine powder obtained through spray drying – which is the same equipment used to make powdered milk – that can be used to make various types of oral hygiene products. The idea is to provide a platform that acts as an adjunct and can be useful, for example, for people with reduced motor skills who are unable to brush their teeth properly, such as older adults and patients with special needs,” says Brighenti. 

Morin was chosen because it is a natural, inexpensive, and easily accessible compound. 

“Morin is a flavonoid that can be obtained from various fruits. But simply eating it isn’t enough; the substance needs to be processed. The idea is to take advantage of this natural compound, its benefits, and its advantages, and transform it all so that it can be used to prevent and treat tooth decay and periodontal disease,” Sales points out.  

Within the research group, Brighenti has been working with other researchers to develop what she calls platforms that allow different types of substances to act on the diseases currently being studied. According to Brighenti, this is necessary because natural products generally do not dissolve well in water. 

“We have a constant flow of saliva. We produce, on average, 1 milliliter of saliva per minute. Anything we put in our mouths is quickly removed by saliva, especially because it has a smell and taste, which stimulates salivary flow. When we have something that sticks to the mucous membrane of the mouth, the inside of our cheeks, and our teeth, it gives us an additional advantage. This controlled release also helps us control the toxicity and stability of the substance,” the professor explains.

In the case of morin, the challenge was to optimize what the group had developed thus far, making it more appealing to potential patients while developing something scalable for the industry.

“We also aim to provide an alternative to products currently available on the market that don’t meet the demand because they have some side effects reported by patients, such as taste changes and increased tartar buildup, as well as stains on the teeth with prolonged use,” Brighenti adds.

“We started developing these systems in the form of tablets, films, and microparticles. But until then, they were too large and unfeasible for oral use. In my PhD, we tried to improve these products by making them smaller. That’s why I developed this format, which looks like powdered milk. I prepared a solution containing sodium alginate and gellan gum to encapsulate morin in a controlled-release system, which is already widely used for drugs but isn’t yet widely used in dentistry,” Sales explains. 

Periodontal disease occurs when there is an accumulation of biofilm or bacterial plaque, a sticky film formed by bacteria and food debris that builds up on the teeth. 

Periodontitis, a severe form of periodontal disease, is considered the sixth most common chronic condition worldwide. In mild cases, bleeding may occur. As the disease progresses, it can lead to tooth loss.

Proper oral hygiene, including brushing, flossing, and using fluoride toothpaste, can considerably decrease this risk.

According to data from the World Health Organization (WHO) in 2022, nearly half of the world’s population (45%) suffers from oral diseases, amounting to approximately 3.5 billion people.

The researchers plan to continue testing morin first in animal models and then in clinical studies to investigate its other properties.  

“We observed with the naked eye that the in vitro biofilm treated with morin in the laboratory is less stained than when treated in its free form. So, it’s possible that there’s an advantage, that this system helps prevent tooth discoloration. We also need to test, for example, whether morin maintains the balance of the oral cavity, because we don’t want to eliminate all bacteria from patients’ mouths,” says Brighenti.

About São Paulo Research Foundation (FAPESP)
The São Paulo Research Foundation (FAPESP) is a public institution with the mission of supporting scientific research in all fields of knowledge by awarding scholarships, fellowships and grants to investigators linked with higher education and research institutions in the State of São Paulo, Brazil. FAPESP is aware that the very best research can only be done by working with the best researchers internationally. Therefore, it has established partnerships with funding agencies, higher education, private companies, and research organizations in other countries known for the quality of their research and has been encouraging scientists funded by its grants to further develop their international collaboration. You can learn more about FAPESP at www.fapesp.br/en and visit FAPESP news agency at www.agencia.fapesp.br/en to keep updated with the latest scientific breakthroughs FAPESP helps achieve through its many programs, awards and research centers. You may also subscribe to FAPESP news agency at http://agencia.fapesp.br/subscribe.